Applying population health approaches to improve safe anticoagulant use in the outpatient setting: the DOAC Dashboard multi-cohort implementation evaluation study protocol.
Anticoagulant
Electronic health records
Implementation science
Medication errors
Pharmacists
Journal
Implementation science : IS
ISSN: 1748-5908
Titre abrégé: Implement Sci
Pays: England
ID NLM: 101258411
Informations de publication
Date de publication:
21 09 2020
21 09 2020
Historique:
received:
27
08
2020
accepted:
10
09
2020
entrez:
22
9
2020
pubmed:
23
9
2020
medline:
3
11
2021
Statut:
epublish
Résumé
Use of direct oral anticoagulants (DOAC) is rapidly growing for treatment of atrial fibrillation and venous thromboembolism. However, incorrect dosing of these medications is common and puts patients at risk of adverse drug events. One way to improve safe prescribing is the use of population health tools, including interactive dashboards built into the electronic health record (EHR). As such tools become more common, exploring ways to understand which aspects are effective in specific settings and how to effectively adapt and implement in existing anticoagulation clinics across different health systems is vital. This three-phase project will evaluate a current nation-wide implementation effort of the DOAC Dashboard in the Veterans Health Administration (VHA) using both quantitative and qualitative methods. Informed by this evaluation, the DOAC Dashboard will be implemented in four new health systems using an implementation strategy derived from the VHA experience and interviews with providers in those new health systems. Quantitative evaluation of the VHA and non-VHA implementation will follow the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) framework. Qualitative interviews with stakeholders will be analyzed using the Consolidated Framework for Implementation Research and Technology Acceptance Models to identify key determinants of implementation success. This study will (1) evaluate the implementation of an EHR-based population health tool for medication management within a large, nation-wide, highly integrated health system; (2) guide the adoption in a set of four different health systems; and (3) evaluation that multi-center implementation effort. These findings will help to inform future EHR-based implementation efforts in a wide variety of health care settings.
Sections du résumé
BACKGROUND
Use of direct oral anticoagulants (DOAC) is rapidly growing for treatment of atrial fibrillation and venous thromboembolism. However, incorrect dosing of these medications is common and puts patients at risk of adverse drug events. One way to improve safe prescribing is the use of population health tools, including interactive dashboards built into the electronic health record (EHR). As such tools become more common, exploring ways to understand which aspects are effective in specific settings and how to effectively adapt and implement in existing anticoagulation clinics across different health systems is vital.
METHODS
This three-phase project will evaluate a current nation-wide implementation effort of the DOAC Dashboard in the Veterans Health Administration (VHA) using both quantitative and qualitative methods. Informed by this evaluation, the DOAC Dashboard will be implemented in four new health systems using an implementation strategy derived from the VHA experience and interviews with providers in those new health systems. Quantitative evaluation of the VHA and non-VHA implementation will follow the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) framework. Qualitative interviews with stakeholders will be analyzed using the Consolidated Framework for Implementation Research and Technology Acceptance Models to identify key determinants of implementation success.
DISCUSSION
This study will (1) evaluate the implementation of an EHR-based population health tool for medication management within a large, nation-wide, highly integrated health system; (2) guide the adoption in a set of four different health systems; and (3) evaluation that multi-center implementation effort. These findings will help to inform future EHR-based implementation efforts in a wide variety of health care settings.
Identifiants
pubmed: 32958020
doi: 10.1186/s13012-020-01044-5
pii: 10.1186/s13012-020-01044-5
pmc: PMC7504868
doi:
Substances chimiques
Anticoagulants
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
83Subventions
Organisme : AHRQ HHS
ID : R18 HS026874
Pays : United States
Références
J Thromb Haemost. 2018 May;16(5):833-841
pubmed: 29460334
JMIR Med Inform. 2018 Jan 24;6(1):e3
pubmed: 29367187
J Clin Epidemiol. 1992 Jun;45(6):613-9
pubmed: 1607900
J Thromb Thrombolysis. 2016 Nov;42(4):566-72
pubmed: 27217043
Chest. 2010 Nov;138(5):1093-100
pubmed: 20299623
Thromb Res. 2018 Mar;163:54-59
pubmed: 29407629
Curr Diab Rep. 2014 Apr;14(4):479
pubmed: 24615333
Int J Hematol. 2014 Aug;100(2):119-24
pubmed: 24952031
Res Pract Thromb Haemost. 2018 Oct 19;3(1):79-84
pubmed: 30656279
Nephron. 1976;16(1):31-41
pubmed: 1244564
Ann Pharmacother. 2017 Dec;51(12):1122-1137
pubmed: 28735551
Implement Sci. 2012 Apr 24;7:37
pubmed: 22530986
Implement Sci. 2015 Feb 12;10:21
pubmed: 25889199
Syst Rev. 2017 Dec 13;6(1):255
pubmed: 29237488
Am J Kidney Dis. 2010 Sep;56(3):486-95
pubmed: 20557989
Clin Appl Thromb Hemost. 2017 May;23(4):384-391
pubmed: 26519049
Qual Res Psychol. 2015 Apr 3;12(2):202-222
pubmed: 27499705
J Thromb Haemost. 2020 Aug;18(8):2025-2030
pubmed: 32428998
J Thromb Thrombolysis. 2018 Jul;46(1):7-11
pubmed: 29605836
J Thromb Thrombolysis. 2014 Oct;38(3):420-1
pubmed: 25037467
Am J Public Health. 1999 Sep;89(9):1322-7
pubmed: 10474547
J Am Coll Cardiol. 2016 Dec 20;68(24):2597-2604
pubmed: 27978942
Nurse Pract. 2014 Oct 15;39(10):40-6
pubmed: 25225978
Circ Cardiovasc Qual Outcomes. 2016 Mar;9(2):182-5
pubmed: 26933047
Chest. 2010 Feb;137(2):263-72
pubmed: 19762550
J Clin Pharmacol. 2016 Jan;56(1):24-38
pubmed: 26100092
Ann Pharmacother. 2019 Aug;53(8):806-811
pubmed: 30854862
Thromb Haemost. 2017 Jan 26;117(2):382-389
pubmed: 27786333
Am J Med. 2016 Nov;129(11):1198-1204
pubmed: 27341955
JACC Cardiovasc Interv. 2014 Dec;7(12):1333-51
pubmed: 25523529